Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients

Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients

Abstract Obesity is a known factor increasing the risk of developing breast cancer and reducing disease free survival. In addition to these well-documented effects, recent studies have shown that obesity is also affecting response to chemotherapy. Among the multiple dysregulations associated with ob...

Full description

Bibliographic Details
Main Authors: Florian Gourgue, Françoise Derouane, Cedric van Marcke, Elodie Villar, Helene Dano, Lieven Desmet, Caroline Bouzin, Francois P. Duhoux, Patrice D. Cani, Bénédicte F. Jordan
Format: Article
Language:English
Published: Nature Publishing Group 2021-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-89385-z

Similar Items

Similar Items